ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 984,93
-0,99%
Dow Jones
38 013,03
-0,97%
DAX
17 932,17
-1,10%
Brent Oil
86,175
-1,27%
Bitcoin
60 072,00
-5,90%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Marinus Pharmaceuticals Inc (MRNS)

  7. Marinus Pharmaceuticals Inc (MRNS) Actualités

MRNS Marinus Pharmaceuticals Inc

1,415
0,015 (1,07%)
Dernière mise à jour : 19:26:02
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Marinus Pharmaceuticals Inc MRNS NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,015 1,07% 1,415 19:26:02
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,42 1,39 1,42 1,40
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
15/4/202413:00BWMarinus Pharmaceuticals Provides Update on the Phase 3 RAISE..
05/4/202422:00BWMarinus Pharmaceuticals Announces Inducement Grants Under..
27/3/202413:41BWMarinus Pharmaceuticals Comments on Patent Challenge by Ovid..
05/3/202422:14EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
05/3/202422:01BWMarinus Pharmaceuticals Provides Business Update and Reports..
22/2/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202413:00BWMarinus Pharmaceuticals to Present at Upcoming Investor..
20/2/202413:00BWMarinus Pharmaceuticals to Provide Business Update and..
16/2/202422:00BWMarinus Pharmaceuticals Announces Inducement Grants Under..
14/2/202422:18EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202421:07EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202418:18EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202416:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202415:04EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202418:13EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
19/1/202422:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202422:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202422:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202422:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202422:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202422:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202422:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202422:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202422:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202422:30BWMarinus Pharmaceuticals Announces Inducement Grants Under..
04/1/202413:04EDGAR2Form 8-K - Current report
04/1/202413:01BWMarinus Pharmaceuticals Reports Preliminary Fourth Quarter..
07/12/202322:30BWMarinus Pharmaceuticals Announces Inducement Grants Under..
28/11/202313:05EDGAR2Form 8-K - Current report
20/11/202322:01BWMarinus Pharmaceuticals Announces Seven Presentations at AES..
14/11/202322:05BWMarinus Pharmaceuticals to Present at the 6th Annual..
09/11/202322:30BWMarinus Pharmaceuticals Announces Inducement Grants Under..
07/11/202313:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202313:11EDGAR2Form 8-K - Current report
07/11/202313:01BWMarinus Pharmaceuticals Provides Business Update and Reports..
07/11/202313:00BWMarinus Pharmaceuticals Initiates Global Access Program for..
24/10/202313:01BWMarinus Pharmaceuticals to Provide Business Update and..
10/10/202322:01EDGAR2Form SC 13G - Statement of acquisition of beneficial..
06/10/202322:00BWMarinus Pharmaceuticals Announces Inducement Grants Under..
28/9/202313:05EDGAR2Form 8-K - Current report
21/9/202322:00BWMarinus Pharmaceuticals to Present at the 2023 Cantor Global..
19/9/202314:02EDGAR2Form 8-K - Current report
19/9/202314:00BWMarinus Pharmaceuticals Highlights Advancing Pipeline and..
12/9/202322:00BWMarinus Pharmaceuticals Announces Speakers for Hybrid..
06/9/202322:01BWMarinus Pharmaceuticals Announces Inducement Grants Under..

Dernières Valeurs Consultées

NASDAQ
MRNS
Marinus Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés